REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Lelab Sdn. Bhd. (Malaysia)

Main Activities: Pharmacies and Drug Stores
Full name: Lelab Sdn. Bhd. Profile Updated: February 05, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Lelab Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Shah Alam. The company operates in the Pharmacies and Drug Stores industry. It was established on September 17, 2003. From the latest financial highlights, Lelab Sdn. Bhd. reported a net sales revenue increase of 6.18% in 2023. Its total assets decreased by 3.03% over the same period. The net profit margin of Lelab Sdn. Bhd. increased by 2.12% in 2023.

Headquarters
18, Jalan Sungai Burung U32/U, Bukit Rimau, Seksyen 32
Shah Alam; Selangor; Postal Code: 40460

Contact Details: Purchase the Lelab Sdn. Bhd. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Lelab Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Lelab Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Lelab Sdn. Bhd. report to view the information.
Incorporation Date:
September 17, 2003
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Lelab Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
6.18%▲
Total operating revenue
6.18%▲
Operating profit (EBIT)
58.87%▲
EBITDA
48.11%▲
Net Profit (Loss) for the Period
63.72%▲
Total assets
-3.03%▼
Total equity
28.28%▲
Operating Profit Margin (ROS)
2.56%▲
Net Profit Margin
2.12%▲
Return on Equity (ROE)
6.21%▲
Debt to Equity Ratio
-33.43%▼
Quick Ratio
0.27%▲
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo